GIP、GLP-1与GLP-2对2型糖尿病骨转换标志物的独立与联合效应
结果显示OGTT较静脉等糖输注显著抑制β-CTX-I,三激素联合输注可达到与OGTT相当的抑制效果,而PINP在OGTT及生理盐水、GLP-2输注中显著降低。提示餐后骨吸收抑制由GIP、GLP-1和GLP-2的叠加效应介导。
要点
- OGTT较静脉等糖输注更显著抑制2型糖尿病患者的骨吸收标志物β-CTX-I。
- GIP、GLP-1与GLP-2联合输注可复制OGTT对β-CTX-I的抑制程度。
- PINP在OGTT及生理盐水、GLP-2输注中显著降低,单用GIP或GLP-1未见降低。
核心结论
- 2型糖尿病患者餐后骨吸收抑制可能由GIP、GLP-1和GLP-2的叠加效应介导。
研究设计与样本
- 参与者接受1次OGTT及5次静脉等糖输注,分别输注生理盐水、GIP、GLP-1、GLP-2和GIP+GLP-1+GLP-2。
主要发现
- OGTT期间β-CTX-I水平较静脉等糖输注显著抑制。
- 静脉等糖输注期间联合输注GIP+GLP-1+GLP-2对β-CTX-I的抑制与OGTT相当。
- 静脉等糖输注GIP、GLP-1及GIP+GLP-1+GLP-2期间未观察到PINP降低。
- OGTT及生理盐水、GLP-2输注期间PINP水平显著降低。
临床怎么用
- 解读2型糖尿病患者骨转换标志物时需考虑肠促胰素及GLP-2的餐后效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Oral glucose tolerance test (OGTT) induces greater acute suppression of bone resorption than isoglycaemic IV glucose infusions (IIGI). OBJECTIVE: To study the separate and combined effects of the gut-derived hormones glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon-like peptide 2 (GLP-2) on postprandial bone turnover. DESIGN: A randomized, crossover study with 6 experimental days. PARTICIPANTS: Ten individuals with type 2 diabetes (T2D). INTERVENTIONS: Over 6 experimental days, participants underwent an OGTT and subsequently 5 IIGIs with infusions of saline, GIP, GLP-1, GLP-2, and GIP + GLP-1 + GLP-2, respectively. MAIN OUTCOME MEASURES: Changes in plasma concentrations of carboxy-terminal telopeptide of type I collagen (β-CTX-I) and procollagen type I N-terminal propeptide (PINP). RESULTS: β-CTX-I levels were significantly suppressed during OGTT compared to IIGI. Concomitant infusion of GIP + GLP-1 + GLP-2 during IIGI led to a suppression of β-CTX-I comparable to the suppression during the OGTT. During IIGI with infusions of GIP, GLP-1, and GIP + GLP-1 + GLP-2 we observed no reduction in PINP. By contrast, PINP levels were significantly reduced during both OGTT and IIGIs with saline and GLP-2, respectively. CONCLUSION: Our findings suggest that postprandial suppression of bone resorption in individuals with T2D is mediated by the additive effects of GIP, GLP-1, and GLP-2.
引用
- Hansen JV, Mathiesen DS, Christensen MB, et al. The Separate and Combined Effects of GIP, GLP-1, and GLP-2 on Markers of Bone Turnover in Type 2 Diabetes. J Clin Endocrinol Metab. 2026. PMID: 40878791. doi:10.1210/clinem/dgaf482
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。